Solomon Moshkevich, PRESIDENT, CLINICALDIAGNOSTICS at Natera, Inc. (NTRA), sold 3,405 shares at $206.16 ($694K) on 2026-05-01, disclosed to the SEC on 2026-05-05.
Scheduled sale ($694k) by PRESIDENT, CLINICALDIAGNOSTICS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $200.95 | 560 | $113K | 16.2% |
| 2 | $201.60 | 520 | $105K | 15.1% |
| 3 | $203.32 | 505 | $103K | 14.8% |
| 4 | $204.47 | 865 | $177K | 25.5% |
| 5 | $205.31 | 400 | $82K | 11.8% |
| 6 | $206.16 | 405 |
| $83K |
| 12.0% |
| 7 | $206.93 | 150 | $31K | 4.5% |
| Total | $203.69 avg | 3,405 | $694K | 100% |
| Filing → |
| NTRA | SELL | 2026-08-05 | $906K | — | Filing → |
| NTRA | SELL | 2026-07-29 | $569K | — | Filing → |
| NTRA | SELL | 2026-07-06 | $819K | — | Filing → |